Drug Trial Radar · NCT07891416
Phase II Clinical Study on Preliminary Efficacy and Safety of ETD-001 Gel for Hypertrophic Scars
Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
90
Planned (sponsor's estimate)
Start
Feb 28, 2027
Primary completion
Dec 31, 2027
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- Etern Therapeutics Wuxi LimitedAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A randomized, double-blind, placebo-controlled multiple dosing study to evaluate the preliminary efficacy and safety of ETD-001 gel for hypertrophic scars. Subjects will be assigned to 3 groups: ETD-001 Dose Group 1, ETD-001 Dose Group 2, and placebo group.
Conditions
- Hypertrophic Scars
Interventions
ETD-001 gelDrug
Topical investigational gel, multiple daily application on hypertrophic scar lesions for scheduled treatment period.
ETD-001 gelDrug
Topical investigational gel (higher concentration), multiple daily application on hypertrophic scar lesions for scheduled treatment period.
PlaceboOther
Matched topical placebo gel, identical appearance and administration regimen, applied on hypertrophic scar lesions
Primary outcomes
What the sponsor says the trial is designed to measure.
- To Evaluate the Preliminary Efficacy of ETD-001 Gel in the Treatment of Hypertrophic Scars :Change from Baseline in Modified Vancouver Scar Scale (mVSS) ScoreTime frame: 4~12weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.